Cancer Screening Strategy for 2025 (Thai-English Bilingual Response)
พื้นฐานการตรวจสุขภาพเพื่อรักษาผิดปกติในการทำงานของเซลล์ 2025 (Cancer Screening Strategy 2025)
Introduction (): In 2025, cancer screening strategies remain a critical component of preventive healthcare, with advancements in technology and a better understanding of cancer biology. The World Health Organization (WHO) continues to emphasize evidence-based screening programs that balance benefits, risks, and costs.
Key Principles (หลักการสำคัญ):
- Evidence-Based Criteria (เกณฑ์ที่พบหลักฐาน):
- The disease should be sufficiently common to warrant screening.
- The test should be sensitive, specific, acceptable to the population, safe, and inexpensive.
- The screening program should ensure adequate diagnostic facilities and high-quality treatment for screen-detected diseases.
- Screening should be repeated at appropriate intervals for diseases with insidious onset (WHO, 2025).
- Screening for Specific Cancers (การตรวจสุขภาพสำหรับมะเร็งชนิดเฉพาะ):
- Cervical Cancer ():
- Pap smears remain the primary screening tool, with follow-up biopsy for abnormal results.
- HPV testing is increasingly used, especially in older women (RAG, 2025).
- Colon Cancer (มะเร็งลำไส้ใหญ่):
- Screening is recommended for individuals aged 45–75, using colonoscopy, sigmoidoscopy, or fecal occult blood tests (FOBT).
- Intervals of 5–10 years for colonoscopy, depending on risk factors (RAG, 2025).
- Breast Cancer (มะเร็งเต้านม):
- Mammography is recommended for women aged 50–74 every 2 years.
- Some guidelines now suggest starting at 40 for high-risk individuals (WHO, 2025).
- Limitations and Biases (ข้อจำกัด):
- Lead Time Bias ():
- Screen-detected cancers appear to have better outcomes due to earlier detection, not necessarily improved treatment.
- Overdiagnosis (การวินิจฉัยเกิน):
- Some cancers detected by screening may never cause symptoms or progress (RAG, 2025).
- Recent Advances (ล่าสุด):
- Liquid Biopsies ():
- Emerging as a potential tool for early detection, particularly for lung and breast cancers (WHO, 2025).
- AI and Big Data ():
- AI-assisted image analysis improves accuracy in radiology and pathology (WHO, 2025).
Patient Safety Considerations (ข้อควรระวังสำหรับผู้ป่วย):
- Always discuss screening options with a healthcare provider, considering individual risk factors and medical history.
- Ensure the screening test is appropriate for the patient’s age and condition.
- Be aware of potential risks, such as false positives/negatives, and unnecessary interventions.
Sources (อ้างอิง):
- WHO. (2025). Cancer. https://www.who.int/health-topics/cancer/
- RAG. (2025). Principles of Oncology.
Note: This information is based on the latest guidelines and research as of December 2025. Always consult a healthcare provider for personalized advice.